OROPHARYNX CANCER, RECURRENT
Clinical trials for OROPHARYNX CANCER, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNX CANCER, RECURRENT trials appear
Sign up with your email to follow new studies for OROPHARYNX CANCER, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy may replace chemo in head and neck cancer treatment
Disease control OngoingThis study compares two treatments for advanced head and neck cancer: the immunotherapy drug pembrolizumab (Keytruda) plus radiation versus standard chemotherapy (cisplatin) plus radiation. About 126 participants with p16-positive cancer will be enrolled. The goal is to see if th…
Matched conditions: OROPHARYNX CANCER, RECURRENT
Phase: PHASE2 • Sponsor: Loren Mell, MD • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
Blood test may spot throat cancer return faster than scans
Knowledge-focused OngoingThis study looks at whether a simple blood test can find signs of HPV-related oropharynx cancer coming back after treatment. Researchers will compare the blood test results with standard imaging and exams in 200 patients. The goal is to see if the blood test is accurate and could…
Matched conditions: OROPHARYNX CANCER, RECURRENT
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 22, 2026 13:55 UTC